Want to Join Our Team?
Learn about Blue Matter's innovative work experiences, enriching development opportunities, team-oriented "People First" culture, and a lot more.
Insights
Access our ever-expanding library of thought leadership resources for strategic leaders and professionals in biopharma. It’s full of useful content addressing industry challenges, best practices, therapeutic markets, innovative ideas, and forward-looking insights.
Featured Whitepaper
Key Success Factors to Building a Best Practice Medical Affairs Organization
Learn More >
Featured Whitepaper
Building Peak Performance Go-to-Market Operations: Capturing the Value of Medical Innovation in a Fast-Changing Landscape
Learn More >
Blog
2021 Outlook for Cell-Based Therapies in Oncology: CAR-T Expansion and Beyond
Blog
Blue Matter Ranked for 2nd Year as One of the 50 Best Consulting Firms to Work for in North America
Whitepaper
The Quiet Revolution in CNS Therapies, Part 2: Outlook for 2021 and Beyond
Whitepaper
The Quiet Revolution in CNS Therapies, Part 1: Why It’s Happening
Blog
Central Nervous System Therapies: Outlook for 2021 & Beyond
Whitepaper
Summary of Blue Matter “Breakfast Club” Meeting No. 7: Artificial Intelligence (AI) in Pharmaceuticals
Whitepaper
Success in Rare Diseases, Part IV: Successfully Implementing Clinical Trials in the Rare Disease Ecosystem
Blog
Central Nervous System Therapies: A Look at Rising Investment Activity
Whitepaper
Summary of Blue Matter “Breakfast Club” Meeting No. 6: Customer Engagement in a Post-COVID World
Blog
Success in Rare Diseases, Part IV: Successfully Implementing Clinical Programs in the Rare Disease Ecosystem
Infographic
Customer Engagement in a Post-COVID World
Blog
Central Nervous System Therapies: Where We’ve Been and the Road Ahead
Whitepaper
Snap Recap: Virtual Panel on Pathways in Europe for US Life Science Companies
Whitepaper
Snap Recap: Webinar on “Pathways to Value” for Biopharma Companies in Ex-US Markets
Whitepaper
Success in Rare Diseases, Part III: Continuous Evidence Generation in the Rare Disease Ecosystem
Blog
Diversity, Equity, and Inclusion: Core to Our “People First” Culture
